Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
about
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapySkewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaHumoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy.Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Acute lymphoblastic leukemia with aleukemic prodrome: preleukemic dynamics and possible mechanisms of immunosurveillance.γδ T-cell conference 2012: close encounters for the fifth time.Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.Current Advances in γδ T Cell-Based Tumor Immunotherapy.CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia
P2860
Q26859775-18FB6F34-1AB3-4165-8F94-43E524C8BDE8Q35935862-85F32A3C-350C-4033-BB9D-CAE8242CF19CQ36040498-598D6A4F-CCB0-40A7-A0D2-134276DCAE00Q36557448-E317FB04-0F50-46E0-9BC4-E5251C923F37Q37127038-FCB5EE59-31F4-472A-8217-3F500118A01FQ37380386-CBE4E303-7FB4-4ED3-8602-91F370FE18F2Q37709461-027D0144-9D4E-49E2-B5FC-814BEBCC1546Q38310258-D458C4D9-10D0-44C5-9DB4-81C8C4BED2A2Q38728528-BB0389FA-4D3A-440E-A169-8D305CDA6C70Q42344559-ADD3269B-B7FA-49DB-B72C-2EB1C7B90F0EQ44208447-A4541136-1F5A-46B9-AFA8-CECD8FECCBB3Q46011813-E92898B8-51F1-4282-B0E8-A38F3D4C932DQ47100174-BDF37AEB-0455-489A-B78C-A69178272F39Q48124547-3154D589-FCC3-446A-8E9D-96A96169207EQ49704420-1BBCFF6F-9199-4BEC-AAAD-B94E525BF6A4Q55311835-E013ABA5-C71E-47F5-A46B-AFDA86B50EC8Q57807709-C060C295-0496-4B75-811E-B511C2B6F74A
P2860
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@en
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@nl
type
label
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@en
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@nl
prefLabel
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@en
Dysfunctional Vγ9Vδ2 T cells a ...... ic lymphocytic leukemia cells.
@nl
P2093
P50
P1433
P1476
Dysfunctional Vγ9Vδ2 T cells a ...... nic lymphocytic leukemia cells
@en
P2093
Amalia Bosia
Anna Guarini
Luca Battistini
Mario Boccadoro
Micol Rigoni
Myriam Foglietta
Sabina Chiaretti
Silvia Peola
P304
P356
10.1182/BLOOD-2012-03-417519
P407
P50
P577
2012-08-29T00:00:00Z